jump to content jump to footer

Use of Multiparametric MRI in Prostate Cancer Treatments: A Prospective Study

The prospective study conducted by LMU Klinikum München investigates the effectiveness of vascular-targeted photodynamic therapy (VTP) and high-intensity focused ultrasound (HIFU) in the treatment of localized prostate cancer.

Using multiparametric MRI (mpMRI), ten patients were monitored over the course of one year to track anatomical changes and potential tumor recurrence.

The results show that mpMRI reliably captures changes in prostate and tumor volumes, with an initial increase in prostate volume, followed by a significant reduction after one year. A recurrence was detected in one patient.

mpMRI proves to be a valuable tool for monitoring tumor recurrence, but further validation in larger studies is required.

Read more about the study here.

mint Lesion usage during a clinical trial read, featuring the TGRM export tool.
Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer
For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…
Read more
Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.
The two-day “RECIST and Beyond” workshop at radCIO Cologne offered intensive hands-on training on RECIST, iRECIST, mRECIST and LI-RADS, with real-case reporting performed directly in mint Lesion.
Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging
How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?
Read more
Screenshot of the mint Lesion interface showing RANO 2.0 configuration, tumor burden calculations, and structured neuro-oncology assessment tools.
mint Lesion fully supports RANO 2.0 implementation with configurable parameters, automated tumor burden calculations, and structured workflows for neuro-oncology clinical trials.
Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion
Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…
Read more
scroll-top